Immunizations

Thirty-five generic manufacturers have signed agreements with the MPP to produce low-cost, generic versions of Pfizer’s oral COVID-19 treatment nirmatrelvir in combination with ritonavir for 95 low- and middle-income countries.

The services, made possible under the Public Readiness and Emergency Preparedness Act, relate to COVID-19 tests, vaccinations and therapeutics, childhood vaccinations, and flu vaccinations.

The “test to treat” initiative enables people to get tested for COVID-19 at a pharmacy, and if they’re positive, receive antiviral pills on the spot at no cost.

Ahead of the U.S. House Energy and Commerce subcommittee hearing on the pandemic’s lessons, NACDS is urging Congress to keep in mind the role pharmacies and pharmacists have played.

Respondents gave pharmacies the highest ratings for ease of access among an array of healthcare destinations.

The COVID-19 One-Year Vaccine report outlines Walmart’s efforts to keep communities safe and healthy amid the pandemic.

At the request of the FDA, the companies have submitted available data on the safety and efficacy of two 3 µg doses as part of a three-dose primary series for children aged 6 months old to 4 years old.

NACDS president and CEO Steve Anderson advises consumers on how pharmacies and their teams are working to help maximize the success of the upcoming COVID-19 OTC test program.